​

Funding Round

Series B - SaNOtize

Series B - SaNOtize

Investment Firm

Overview

SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.

Announced Date

Aug 24, 2022

Funding Type

Series B

Highlights

Location

North America

Social

Investor Lead

OurCrowd

OurCrowd

OurCrowd is a early_stage_venture and late_stage_venture firm.

Horizons Ventures

Horizons Ventures

Horizons Ventures is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorAgricultural Bank of China
Participant InvestorHorizons Ventures
Participant InvestorOurCrowd

Round Details and Background

SaNOtize raised $24000000 on 2022-08-24 in Series B

SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 12, 2020
Series A - SaNOtize
2-2.5M
Jan 01, 2018
Angel Round - SaNOtize
1-undefined
Aug 24, 2022
Series B - SaNOtize
3-24.0M

Recent Activity

There is no recent news or activity for this profile.